A carregar...

“Matching” the “mismatch” repair deficient prostate cancer with immunotherapy

Mismatch repair gene mutations are uncommon in advanced prostate cancer; however, in those harboring these alterations, immune checkpoint blockade can be effective. As such, assays that can accurately identify these men are critically important. Cell-free circulating tumor DNA-based sequencing appro...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Schweizer, Michael T., Yu, Evan Y.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7123990/
https://ncbi.nlm.nih.gov/pubmed/31900277
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-19-3780
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!